Luminex and One Lambda Renew 10-Year Strategic Partnership

Luminex Corporation LMNX and One Lambda, Inc. have agreed to a long-term renewal of their 10-year strategic partnership aimed at developing platforms and technologies for human leukocyte antigen typing and antibody screening for the organ transplantation market. Begun in 2000, their dedicated collaboration has resulted in the creation of innovative products that have made pre- and post-transplant diagnostics faster, and more cost-efficient.